Paul Colvin serves as executive vice president of biopharma partnerships for PPD. In this role, he is responsible for developing customized solutions for the company’s partners and clients to help meet their evolving needs. His operational leadership, coupled with his experience with and knowledge of both the industry and PPD’s unique capabilities, gives him a deep understanding of client needs and equips him with the expertise necessary to develop solutions that meet those needs.
Most recently, Colvin served as executive vice president of global clinical development, providing strategic direction and oversight to the company’s Phase II-IV organization in the Americas, Europe, Middle East and Africa (EMEA) and Asia-Pacific. He was named to this global leadership role in 2010, having joined PPD as senior vice president of clinical development of North America in 2007.
Colvin brings to his work a strong background in clinical development garnered in the pharmaceutical industry. Previously, at Eli Lilly and Company, he held a series of positions of increasing responsibility, having served as chief operations officer for the global cardiovascular brand team and European clinical operations; global clinical operations manager for oncology project teams; and clinical project management leader for the oncology project team. He also served as director of corporate clinical operations and global patient enrollment optimization.
Colvin earned a bachelor’s degree in pharmacy from Butler University in Indiana and is a registered pharmacist in the same state. He also participated in London Business School’s advanced executive development program.